A statement released earlier today by Zacks Investment Research about Inovalon Holdings Inc (NASDAQ:INOV) raises the target price to $16.00
- Updated: October 17, 2016
Boasting a price of $13.88, Inovalon Holdings Inc (NASDAQ:INOV) traded 0.73% higher on the day. With the last stock price close down -18.60% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Inovalon Holdings Inc has recorded a 50-day average of $15.22 and a two hundred day average of $17.01. Volume of trade was up over the average, with 896,208 shares of INOV changing hands over the typical 621,435
Inovalon Holdings Inc (NASDAQ:INOV) had its stock price target increased to $16.00 by Zacks Investment Research in an issued report announced Monday October 17, 2016. The upped price target suggests a potential upside of 0.15% based on the company's last stock close price.
See Chart Below
Inovalon Holdings Inc has a 52 week low of $13.50 and a 52 week high of $23.87 with a P/E ratio of 46.79 The company’s market cap is currently $0.
In addition to Zacks Investment Research reporting its stock price target, a total of 7 brokerages have issued a research note on the company. The average target is $20.00 with zero analysts rating the company a strong buy, zero analysts rating the company a buy, zero analysts rating the company a hold, zero equity analysts rating the company a underperform, and lastly 0 brokers rating the stock a sell.
General Information About Inovalon Holdings Inc (NASDAQ:INOV)
Inovalon Holdings, Inc. is a technology company. The Company combines advanced cloud-based data analytics and data-driven intervention platforms to provide services for health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. The Company operates through developing cloud-based data analytics and data-driven intervention platforms segment and provides related services to its clients. The Company's datasets, integration technologies, predictive analytics and subject matter expertise allows the Company to provide platforms. Its analytics platforms identify gaps in care, quality, data integrity and financial performance in its clients' datasets. The Company's data analytics and intervention platforms consist of four primary components: data integration, advanced analytics, intervention platforms and business processing. The Company integrates data into its systems through its Extract, Transform, Load (ETL) tools and processes.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.